Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Narashino-shi, Japan Clinical Trials

A listing of Narashino-shi, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (3) clinical trials

Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind Placebo-controlled Trial

Accumulating evidence suggests a key role of the N-methyl-D-aspartate (NMDA) receptor in the pathophysiology of post-traumatic stress disorder (PTSD). Recent studies suggest that the NMDA receptor antagonist ifenprodil tartrate may be a potential therapeutic drug for PTSD. The purpose of this study is to confirm whether ifenprodil tartrate is effective ...

Phase

8.13 miles

Learn More »

Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind Placebo-controlled Trial

Tipepidine (3-[di-2-thienylmethylene]-1-methylpiperidine) has been used solely as a nonnarcotic antitussive in Japan since 1959. The safety of tipepidine in children and adults has already been established. It is reported that tipepidine inhibits G-protein-coupled inwardly rectifying potassium (GIRK)-channel currents. The inhibition of GIRK channels by tipepidine is expected to modulate the ...

Phase

8.13 miles

Learn More »

Open-label Clinical Trial of Lacosamide in ALS

Lacosamide is administered for patients with amyotrophic lateral sclerosis (ALS). This clinical trial is open-label, single group and before and after comparison study. Dosage of lacosamide is increased from 100mg to 400mg for 4 weeks. Safety of lacosamide administration in ALS is primary endpoint. Nerve excitability, fasciculation and muscle cramp ...

Phase

8.24 miles

Learn More »